IDEXX Laboratories, Inc.
IDXX
$752.88
-$3.08-0.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.38% | 11.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.38% | 11.12% | |||
| Cost of Revenue | 1.73% | 10.58% | |||
| Gross Profit | -1.64% | 11.45% | |||
| SG&A Expenses | 2.04% | 4.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.90% | 8.00% | |||
| Operating Income | -4.88% | 17.85% | |||
| Income Before Tax | -4.85% | 16.86% | |||
| Income Tax Expenses | 2.63% | 1.42% | |||
| Earnings from Continuing Operations | -6.59% | 21.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.59% | 21.14% | |||
| EBIT | -4.88% | 17.85% | |||
| EBITDA | -4.24% | 16.61% | |||
| EPS Basic | -6.22% | 22.51% | |||
| Normalized Basic EPS | -4.47% | 18.17% | |||
| EPS Diluted | -6.34% | 22.64% | |||
| Normalized Diluted EPS | -4.47% | 18.19% | |||
| Average Basic Shares Outstanding | -0.39% | -1.11% | |||
| Average Diluted Shares Outstanding | -0.39% | -1.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||